Argen X Se Adr (ARGX)

Sep 30, 2026

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Argenx Se (ARGX) and Obsidian Therapeutics (OBX) - theglobeandmail.com

Sep 30, 2026

Sep 30, 2026

argenx SE (ARGX) Stock Price, News, Quote & History - Yahoo Finance

Sep 30, 2026

Sep 29, 2026

argenx SE (ARGX) stock price, news, quote and history - uk.finance.yahoo.com

Sep 29, 2026

Sep 29, 2026

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline - GlobeNewswire Inc.

Sep 29, 2026

Sep 28, 2026

No-Moat Argenx's Growth Led by Vyvgart; Pipeline Brings Long-Term Diversification - Morningstar

Sep 28, 2026

Sep 25, 2026

US markets mixed as NY Empire State manufacturing index surges in August - scanx.trade

Sep 25, 2026

Sep 18, 2026

argenx appoints two non-executive directors to board By Investing.com - Investing.com India

Sep 18, 2026

Sep 17, 2026

argenx appoints two non-executive directors to board - Investing.com

Sep 17, 2026

Sep 14, 2026

argenx at Morgan Stanley conference: broadening beyond vyvgart By Investing.com - Investing.com Australia

Sep 14, 2026

Sep 14, 2026

argenx at Morgan Stanley conference: broadening beyond vyvgart - Investing.com

Sep 14, 2026

Sep 08, 2026

argenx at wells fargo healthcare conference: broadening beyond vyvgart By Investing.com - Investing.com Australia

Sep 08, 2026

Sep 08, 2026

argenx at wells fargo healthcare conference: broadening beyond vyvgart - investing.com

Sep 08, 2026

Sep 05, 2026

Argenx Se Stock Price Forecast. Should You Buy ARGX? - StockInvest.us

Sep 05, 2026

Sep 03, 2026

argenx SEADR Key Financial Ratios – Valuation, Profitability & More - Value Research

Sep 03, 2026

Sep 03, 2026

Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2026 Commentary - Seeking Alpha

Sep 03, 2026

Sep 01, 2026

argenx to Present at Upcoming Investor Conferences - Barchart.com

Sep 01, 2026

Aug 28, 2026

Resilient Argenx stock holds near record highs after Forte Biosciences acquisition - ad-hoc-news.de

Aug 28, 2026

Aug 27, 2026

Resilient Argenx stock touches fresh all-time high after Forte Biosciences deal - ad-hoc-news.de

Aug 27, 2026

Aug 27, 2026

Argenx stock hits all-time high at 1059.86 USD By Investing.com - Investing.com South Africa

Aug 27, 2026

Aug 27, 2026

argenx Completes Acquisition of Forte Biosciences, Inc. - Barchart.com

Aug 27, 2026

Aug 27, 2026

Forte Biosciences Director David W. Gryska Sells Entire Stake Amid Merger with argenx BV - Kalkine Media

Aug 27, 2026

Aug 26, 2026

Why is Argen-X stock climbing today? By Investing.com - Investing.com UK

Aug 26, 2026

Aug 26, 2026

UBS upgrades argenx stock rating on Vyvgart sales outlook By Investing.com - Investing.com India

Aug 26, 2026

Aug 26, 2026

UBS Just Upgraded Argenx Stock. Here's Why. - Yahoo Finance

Aug 26, 2026

Aug 25, 2026

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX) - The Globe and Mail

Aug 25, 2026

Aug 24, 2026

Deutsche Bank downgrades argenx stock to Hold on valuation By Investing.com - Investing.com Nigeria

Aug 24, 2026

Aug 24, 2026

Deutsche Bank downgrades argenx stock to Hold on valuation - Investing.com

Aug 24, 2026

Aug 20, 2026

ETFs Investing in argenx SE Sponsored ADR Stocks - TradingView

Aug 20, 2026

Aug 19, 2026

Resilient Argenx stock climbs after positive myositis data and fresh analyst targets - Ad-hoc-news.de

Aug 19, 2026

Aug 18, 2026

RBC Capital raises argenx stock price target on myositis data - Investing.com

Aug 18, 2026

Aug 18, 2026

Strong Argenx stock extends rally after Vyvgart trial win and analyst target hikes. - Ad-hoc-news.de

Aug 18, 2026

Aug 18, 2026

Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm

Aug 18, 2026

Aug 18, 2026

Citizens raises argenx stock price target to $1,200 on trial results - Investing.com

Aug 18, 2026

Aug 18, 2026

Argenx's Positive Vyvgart Data in Autoimmune Indication Supports Growth and FB102 Broadens Portfolio - morningstar.com

Aug 18, 2026

Aug 18, 2026

Resilient Argenx stock jumps after positive Vyvgart Phase 3 data - Ad-hoc-news.de

Aug 18, 2026

Aug 17, 2026

TD Cowen raises argenx stock price target to $1,353 on myositis outlook - Investing.com Australia

Aug 17, 2026

Aug 17, 2026

ARGX Stock Price, Quote & Chart - ChartMill

Aug 17, 2026

Aug 17, 2026

European ADRs Started The Week Slightly Higher In US Trading - Finimize

Aug 17, 2026

Aug 17, 2026

There are notable gap-ups and gap-downs in today's session. - ChartMill

Aug 17, 2026

Aug 17, 2026

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Movi - Benzinga

Aug 17, 2026

Aug 17, 2026

Argx stock hits all-time high at 954.5 USD By Investing.com - Investing.com Canada

Aug 17, 2026

Aug 17, 2026

argenx reports positive Phase 3 ALKIVIA results - grafa.com

Aug 17, 2026

Aug 17, 2026

Zai Lab, argenx report positive phase 3 data for myositis drug - Investing.com India

Aug 17, 2026

Aug 17, 2026

Why is Argen-X stock surging today? - Investing.com

Aug 17, 2026

Aug 17, 2026

Why is Argen-X stock surging today? By Investing.com - Investing.com India

Aug 17, 2026

Aug 17, 2026

Argenx shares jump after positive Phase 3 results in autoimmune myositis trial - Investing.com South Africa

Aug 17, 2026

Aug 14, 2026

T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - Stock Titan

Aug 14, 2026

Aug 14, 2026

Forte Biosciences earnings on deck as $2.2 billion argenx deal nears - Investing.com

Aug 14, 2026

Aug 13, 2026

Argenx stock holds near recent highs as half year 2026 update and Forte deal shape outlook - AD HOC NEWS

Aug 13, 2026

Aug 10, 2026

Weekly Recap: Cash tender offer for Forte and EGM on director appointments - TradingView

Aug 10, 2026